TB/Micobactérias Não Tuberculosas

Revisão sistemática | Xpert MTB/XDR para detecção de tuberculose pulmonar e resistência a isoniazida, fluoroquinolonas, etionamida e amicacina.

26 Mai, 2022 | 12:46h

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin – Cochrane Library

Resumo: Xpert MTB/XDR, a rapid test for resistance to tuberculosis drugs – Cochrane Library

Estudo de modelagem | 20% dos casos de tuberculose multirresistente em crianças poderiam ser evitados por meio de testagem e tratamento domiciliar.

26 Mai, 2022 | 12:45h

Comunicado de imprensa: 20% of multi-drug resistant tuberculosis cases in children could be averted by household testing and treatment – London School of Hygiene & Tropical Medicine

Estudo original: The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study – The Lancet Global Health

Comentário convidado: Investing in drug-resistant tuberculosis household contact management and preventive treatment – The Lancet Global Health

OMS alerta para cursos medicamentosos mais curtos para tuberculose resistente.

6 Mai, 2022 | 17:07h

WHO calls for shorter drug course for resistant TB – CIDRAP

Comunicação rápida: Key changes to the treatment of drug-resistant tuberculosis – World Health Organization

Revisão | Estratégias de tratamento antituberculose e desenvolvimento de medicamentos: desafios e prioridades.

3 Mai, 2022 | 15:59h

Anti-tuberculosis treatment strategies and drug development: challenges and priorities – Nature Reviews Microbiology (se o acesso a este link for pago, tente este)

Comunicado de imprensa: A major update on global tuberculosis fight – Hackensack Meridian Health

Comentário no Twitter

Anti-tuberculosis treatment strategies and drug development: challenges and prioritieshttps://t.co/nZlcEwTDLP

In this Review, Dartois and Rubin explore challenges and priorities for anti-tuberculosis treatment strategies and drug development.@vdartois1 pic.twitter.com/t6RQoaFb8C

— Nature Reviews Microbiology (@NatureRevMicro) April 27, 2022

Testes moleculares rápidos para tuberculose e resistência a medicamentos: uma síntese de evidência qualitativa do ponto de vista do receptor e do provedor.

28 Abr, 2022 | 11:57h

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views – Cochrane Library

Resumo: Rapid molecular tests for tuberculosis and tuberculosis drug resistance: the views and experiences of people who are tested and healthcare providers – Cochrane Library

Comentário: Molecular tests for TB: Global rollout of rapid molecular tests for tuberculosis over the last 12 years – Liverpool School of Tropical Medicine

Tuberculose resistente a medicamentos – Desenvolvimentos mais recentes em epidemiologia, diagnóstico e tratamento.

14 Abr, 2022 | 17:25h

Drug resistant TB – latest developments in epidemiology, diagnostics and management – International Journal of Infectious Diseases

Conteúdos relacionados:

Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment

Randomized Trial: 9-month Treatment for Multi-drug Resistant TB is as Effective as 24-month Treatment

Canadian Tuberculosis Standards – 8th Edition.

Guideline: Treatment of Drug-Resistant Tuberculosis

NICE Guideline: Tuberculosis

The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis

Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives

Diretrizes canadenses para tuberculose – 8ª edição.

29 Mar, 2022 | 14:10h

Página principal: Canadian Tuberculosis Standards – 8th Edition – Canadian Journal of Respiratory, Critical Care, and Sleep Medicine

Preface

Chapter 1: Epidemiology of tuberculosis in Canada
Chapter 2: Transmission and pathogenesis of tuberculosis

Chapter 3: Diagnosis of tuberculosis disease and drug-resistant tuberculosis

Chapter 4: Diagnosis of tuberculosis infection

Chapter 5: Treatment of tuberculosis disease

Chapter 6: Tuberculosis preventive treatment in adults
Chapter 7: Extra-pulmonary tuberculosis

Chapter 8: Drug-resistant tuberculosis

Chapter 9: Pediatric tuberculosis

Chapter 10: Treatment of active tuberculosis in special populations

Chapter 11: Tuberculosis contact investigation and outbreak management

Chapter 12: An introductory guide to tuberculosis care to improve cultural competence for health care workers and public health professionals serving Indigenous Peoples of Canada

Chapter 13: Tuberculosis surveillance and tuberculosis infection testing and treatment in migrants

Chapter 14: Prevention and control of tuberculosis transmission in healthcare settings

Chapter 15: Monitoring tuberculosis program performance

Revisão sistemática | Rastreamento de sintomas e radiografia torácica para identificar tuberculose pulmonar ativa em adultos HIV-negativos e adultos com status de HIV desconhecido.

29 Mar, 2022 | 14:05h

Symptom‐ and chest‐radiography screening for active pulmonary tuberculosis in HIV‐negative adults and adults with unknown HIV status – Cochrane Library

Resumo: How accurate are asking about symptoms and doing a chest X-ray to screen for tuberculosis of the lungs among adults who are HIV-negative or with unknown HIV status? – Cochrane Library

Coleção Especial Cochrane | Diagnóstico de tuberculose.

25 Mar, 2022 | 16:12h

Diagnosing tuberculosis – Cochrane Library

M-A | Rastreamento da tuberculose entre pacientes HIV-positivos internados.

25 Mar, 2022 | 15:30h

Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis – The Lancet HIV